Health
State of Health
US FDA approves Gilead's remdesivir as COVID-19 treatment

Just Earth News | @justearthnews | 22 Oct 2020 Print

US FDA approves Gilead's remdesivir as COVID-19 treatment COVID19

Pixabay

Washington/Xinhua: The U.S. Food and Drug Administration (FDA) on Thursday approved Gilead Sciences' antiviral drug Veklury (remdesivir) as a treatment for COVID-19.

Previously authorized by the FDA for emergency use to treat COVID-19, Veklury is now the first and only approved COVID-19 treatment in the United States, said Gilead in a statement.

Veklury is indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization, Gilead said.

Clinical trials show Veklury shortened time to recovery by five days in hospitalized COVID-19 patients, according to the company.